Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive factors in prostate needle biopsy.

R Mazzucchelli1, A Lopéz-Beltran, M Scarpelli

  • 1Institute of Pathological Anatomy, University of Ancona, Umberto 1 degrees Hospital, I-60020 Torrette (AN), Italy. r. montironi@unian.it

Pathologica
|January 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.

Journal of neuro-oncology·2022
Same author

Quantification of bone marrow edema by MRI of the sacroiliac joints in patients diagnosed with axial spondyloarthritis: results from the ESPeranza cohort.

Scandinavian journal of rheumatology·2021
Same author

Pathology without microscope: From a projection screen to a virtual slide.

Pathology, research and practice·2020
Same author

Risk of acute myocardial infarction among new users of bisphosphonates: a nested case-control study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Epigenetic modulations and lineage plasticity in advanced prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Virchows Archiv : an international journal of pathology·2020

Prostate cancer (PCa) remains a significant health concern for men. Accurate pathological examination of biopsy specimens is crucial for effective treatment and improved patient outcomes in prostate cancer care.

Area of Science:

  • Oncology
  • Pathology
  • Urology

Background:

  • Prostate cancer (PCa) is a leading cause of cancer morbidity and mortality in men.
  • Despite advances in detection and treatment, PCa-related morbidity and mortality rates have not significantly decreased.
  • Accurate pathological assessment of prostate biopsy specimens is vital for treatment decisions and prognosis.

Purpose of the Study:

  • To emphasize the critical role of pathology in prostate cancer management.
  • To highlight the need for personalized therapeutic approaches based on patient-specific features.
  • To underscore the importance of tailoring treatment to clinical, morphological, and molecular characteristics.

Main Methods:

  • Review of current diagnostic and prognostic indicators in prostate cancer.

Related Experiment Videos

  • Analysis of the impact of pathological findings on treatment selection.
  • Integration of clinical, morphological, and molecular data for personalized medicine.

    • Main Results:

    • Pathological examination is a cornerstone for determining appropriate prostate cancer therapies.
    • Detailed analysis of biopsy specimens influences patient outcome prediction.
    • Personalized treatment strategies informed by comprehensive patient data are essential.

    Conclusions:

    • The precise examination of prostate biopsy specimens by pathologists is indispensable for effective prostate cancer management.
    • Tailoring therapeutic strategies to individual patient profiles, including clinical, morphological, and molecular features, is key to improving outcomes.
    • Continued advancements in pathological analysis will further enhance the precision of prostate cancer treatment.